$168 Million is the total value of SALEM CAPITAL MANAGEMENT INC's 75 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 10.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MSFT | Sell | Microsoft | $11,596,000 | +1.6% | 49,182 | -4.2% | 6.90% | -4.8% |
| HON | Sell | Honeywell Int'l | $8,778,000 | +1.4% | 40,439 | -0.7% | 5.23% | -5.0% |
| BAC | Sell | Bank of America Corp. | $8,770,000 | +27.6% | 226,663 | -0.0% | 5.22% | +19.6% |
| WY | Sell | Weyerhaeuser Co. | $7,367,000 | +5.2% | 206,945 | -0.9% | 4.39% | -1.4% |
| GLW | Sell | Corning | $6,972,000 | +19.7% | 160,250 | -1.0% | 4.15% | +12.2% |
| JNJ | Sell | Johnson & Johnson | $4,155,000 | +2.8% | 25,282 | -1.6% | 2.47% | -3.6% |
| T | Sell | AT & T Corp. | $3,286,000 | +3.6% | 108,543 | -1.6% | 1.96% | -2.9% |
| PYPL | Sell | PayPal Holdings Inc. | $3,042,000 | -4.1% | 12,525 | -7.6% | 1.81% | -10.1% |
| DVN | Sell | Devon Energy | $2,809,000 | +37.7% | 128,561 | -0.4% | 1.67% | +29.1% |
| ABT | Sell | Abbott Laboratories | $2,371,000 | +8.4% | 19,783 | -1.0% | 1.41% | +1.6% |
| VTRS | Sell | Viatris Inc. | $1,584,000 | -27.3% | 113,399 | -2.5% | 0.94% | -31.9% |
| HD | Sell | Home Depot Inc. | $1,404,000 | +13.7% | 4,600 | -1.1% | 0.84% | +6.6% |
| JOF | Sell | Japan Smaller Capitalization F | $1,315,000 | +0.5% | 141,353 | -2.3% | 0.78% | -5.8% |
| INTC | Sell | Intel | $1,282,000 | -77.6% | 20,037 | -82.6% | 0.76% | -79.1% |
| LLY | Sell | Lilly, Eli | $802,000 | +9.4% | 4,294 | -1.2% | 0.48% | +2.6% |
| SYK | Sell | Stryker | $353,000 | -47.6% | 1,450 | -47.3% | 0.21% | -50.9% |
| ABBV | Sell | AbbVie Inc. | $206,000 | -45.1% | 1,900 | -45.7% | 0.12% | -48.3% |
| HAL | Exit | Halliburton Co. | $0 | – | -89,350 | -100.0% | -1.07% | – |
| DD | Exit | DuPont de Nemours Inc. | $0 | – | -57,410 | -100.0% | -2.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-04-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft | 38 | Q3 2022 | 8.6% |
| Honeywell Int'l | 38 | Q3 2022 | 5.5% |
| Merck & Co. | 38 | Q3 2022 | 5.6% |
| Weyerhaeuser Co. | 38 | Q3 2022 | 4.8% |
| Cisco Systems | 38 | Q3 2022 | 5.3% |
| Johnson & Johnson | 38 | Q3 2022 | 5.1% |
| Pfizer Inc. | 38 | Q3 2022 | 5.3% |
| International Paper | 38 | Q3 2022 | 4.6% |
| CVS Health Corporation | 38 | Q3 2022 | 5.6% |
| Verizon Communications | 38 | Q3 2022 | 3.1% |
View SALEM CAPITAL MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-29 |
| 13F-HR | 2022-07-27 |
| 13F-HR | 2022-04-07 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-10-12 |
| 13F-HR | 2021-07-13 |
| 13F-HR | 2021-04-15 |
| 13F-HR | 2021-01-12 |
| 13F-HR | 2020-10-13 |
| 13F-HR | 2020-07-20 |
View SALEM CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.